Xylem (NYSE:XYL – Get Free Report) updated its FY24 earnings guidance on Thursday. The company provided earnings per share guidance of $4.22-$4.24 for the period, compared to the consensus earnings per share estimate of $4.26. The company issued revenue guidance of $8.50 billion, compared to the consensus revenue estimate of $8.58 billion. Xylem also updated its FY 2024 guidance to 4.220-4.240 EPS.
Xylem Stock Down 1.9 %
Shares of NYSE XYL traded down $2.32 during mid-day trading on Friday, hitting $119.46. The company had a trading volume of 1,925,015 shares, compared to its average volume of 981,687. The company has a current ratio of 1.96, a quick ratio of 1.33 and a debt-to-equity ratio of 0.19. The firm has a 50-day simple moving average of $132.78 and a two-hundred day simple moving average of $135.13. The company has a market capitalization of $29.02 billion, a PE ratio of 34.93, a price-to-earnings-growth ratio of 2.14 and a beta of 1.05. Xylem has a one year low of $93.86 and a one year high of $146.08.
Xylem (NYSE:XYL – Get Free Report) last posted its quarterly earnings results on Thursday, October 31st. The industrial products company reported $1.11 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.11. Xylem had a return on equity of 9.61% and a net margin of 9.85%. The firm had revenue of $2.10 billion during the quarter, compared to the consensus estimate of $2.17 billion. During the same period last year, the company earned $0.99 earnings per share. The business’s revenue was up .2% compared to the same quarter last year. On average, equities analysts expect that Xylem will post 4.26 EPS for the current year.
Xylem Dividend Announcement
Wall Street Analysts Forecast Growth
A number of research analysts have recently commented on the stock. Royal Bank of Canada decreased their price objective on shares of Xylem from $163.00 to $162.00 and set an “outperform” rating for the company in a research report on Friday. Stifel Nicolaus raised their price objective on Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. TD Cowen reiterated a “hold” rating and set a $138.00 target price on shares of Xylem in a research note on Tuesday, September 3rd. Robert W. Baird dropped their price target on Xylem from $175.00 to $154.00 and set an “outperform” rating on the stock in a research note on Friday. Finally, UBS Group initiated coverage on shares of Xylem in a report on Tuesday, August 13th. They issued a “buy” rating and a $165.00 price objective on the stock. Four equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $148.25.
Check Out Our Latest Report on XYL
Xylem Company Profile
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Read More
- Five stocks we like better than Xylem
- How to Use Stock Screeners to Find Stocks
- Battle of the Retailers: Who Comes Out on Top?
- What Are the U.K. Market Holidays? How to Invest and Trade
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Upcoming IPO Stock Lockup Period, Explained
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.